YPSOMED HLDG SF 1415/ CH0019396990 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 5.53 bill.EUR | - | - |
Assets
| 2019 - in mill. CHF |
2020 - in mill. CHF |
2021 - in mill. CHF |
2022 - in mill. CHF |
2023 Swiss GAAP FER in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 268.6000 | 309.1000 | 334.4000 | 336.2000 | 387.6770 | ||||||
| Intangible Assets | 81.4000 | 102.5000 | 160.7000 | 190.8000 | 231.7380 | ||||||
| Long-Term Investments | 8.7000 | .2000 | 2.7000 | 2.6000 | 2.6390 | ||||||
| Fixed Assets | 409 | 488.4000 | 532.5000 | 563.3000 | 653.5520 | ||||||
| Inventories | 52.4000 | 56.3000 | 63.4000 | 68.3000 | 57.7040 | ||||||
| Accounts Receivable | 89.7000 | 76.3000 | 72.7000 | 87 | 93.3360 | ||||||
| Cash and Cash Equivalents | 12.1000 | 13.4000 | 19.3000 | 17 | 25.2240 | ||||||
| Current Assets | 178.8000 | 186.4000 | 185.1000 | 193.6000 | 208.3270 | ||||||
| Total Assets | 587.7000 | 674.7000 | 717.7000 | 756.9000 | 861.8790 | ||||||
Liabilities
| 2019 - in mill. CHF |
2020 - in mill. CHF |
2021 - in mill. CHF |
2022 - in mill. CHF |
2023 Swiss GAAP FER in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 19.3000 | 24 | 34.6000 | 17.4000 | 19.6200 | ||||||
| Long-term debt | 10 | 10 | 32.5000 | 110 | 0.0000 | ||||||
| Liabilities to Banks | 122 | 193 | 215 | 267 | - | ||||||
| Provisions | 6 | 7.3000 | 8.6000 | 9.3000 | 16.1750 | ||||||
| Liabilities | 209 | 299.5000 | 322.3000 | 364.4000 | 299.5460 | ||||||
| Share Capital | 179 | 179 | 179 | 178.9940 | - | ||||||
| Total Equity | 378.8000 | 375.2000 | 395.4000 | 392.5000 | 562.3330 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 587.7000 | 674.7000 | 717.7000 | 756.9000 | 861.8790 | ||||||
Income Statement
| 2019 - in mill. CHF |
2020 - in mill. CHF |
2021 - in mill. CHF |
2022 - in mill. CHF |
2023 Swiss GAAP FER in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 453.8000 | 393.9000 | 403.7000 | 464.8000 | 497.4600 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 73.3000 | 9.3000 | 9.3000 | 28.6000 | 60.5940 | ||||||
| Interest Income | - | - | - | - | -3.9570 | ||||||
| Income Before Taxes | 69.9000 | 7.5000 | 6.1000 | 25.5000 | - | ||||||
| Income Taxes | -9.8000 | 4 | -.3000 | -2.4000 | 5.3620 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | - | - | ||||||
| Net Income | 60.1000 | 11.5000 | 5.8000 | 23.1000 | 51.2750 | ||||||
Per Share
Cash Flow
| 2019 - in mill. CHF |
2020 - in mill. CHF |
2021 - in mill. CHF |
2022 - in mill. CHF |
2023 Swiss GAAP FER in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 59.9000 | 49.1000 | 85.8000 | - | 129.5310 | ||||||
| Cash Flow from Investing Activities | -128.4000 | -115.8000 | -106.9000 | - | -122.0190 | ||||||
| Cash Flow from Financing | 49.1000 | 68.7000 | 26.7000 | - | 1.2650 | ||||||
| Decrease / Increase in Cash | -20 | 1.3000 | 5.9000 | - | - | ||||||
| Employees | 1,604 | 1,714 | 1,824 | 1,923 | 2,059 | ||||||
